Please login first
Rodriguez-Rodriguez Miguel  - - - 
Top co-authors See all
Ana Fernández

406 shared publications

R. López

185 shared publications


174 shared publications

Carlos Duque

66 shared publications

R. Melero

48 shared publications

Publication Record
Distribution of Articles published per year 
(2006 - 2017)
Total number of journals
published in
Publications See all
Article 0 Reads 0 Citations Epiglotitis aguda en el adulto. Presentación de varios casos clínicos M. Rodríguez-Rodríguez, A. Murcia-Olagüenaga, J. Rodríguez-A... Published: 01 November 2017
Medicina de Familia. SEMERGEN, doi: 10.1016/j.semerg.2017.09.004
DOI See at publisher website
BOOK-CHAPTER 0 Reads 0 Citations Change in the Hydrological Functioning of Sand Dune Ponds in Doñana National Park (Southern Andalusia, Spain) A. Fernández-Ayuso, M. Rodríguez-Rodríguez, J. Benavente, Ma... Published: 28 October 2017
Environmental Earth Sciences, doi: 10.1007/978-3-319-69356-9_17
DOI See at publisher website
Article 0 Reads 0 Citations Component-resolved diagnosis in hymenoptera allergy D. Antolín-Amérigo, B. Ruiz-León, E. Boni, T. Alfaya-Arias, ... Published: 01 July 2017
Allergologia et Immunopathologia, doi: 10.1016/j.aller.2017.05.003
DOI See at publisher website
Article 0 Reads 0 Citations AB1125-HPR Health- Related Quality of Life in Patients with Chronic Inflammatory Arthropathies and Biologic Therapy M. Άlvarez-Payero, F. Maceiras, R. Melero, C. Mouriño, M. Ro... Published: 01 June 2016
Annals of the Rheumatic Diseases, doi: 10.1136/annrheumdis-2016-eular.3761
DOI See at publisher website
ABS Show/hide abstract
Background Chronic inflammatory arthropaties-CIA (RA-rheumatoid arthritis, PA-psoriatic arthritis, and AS-ankylosing spondylitis) cause functional disability and reduces health-related quality of life (HRQoL) of patients1 Objectives To evaluate HRQoL in patients with CIA and biologic therapy (BT), as a measure of patient reported outcome. Methods Descriptive cross-sectional study (August 2014) in a tertiary hospital. Inclusion criteria:a)adult patients with RA, PA, SA and other CIA (O) attended at the Rheumatology Service and b)≥2 months of treatment with BT (sc/iv adalimumab-ADA, sc/iv etanercept-ETA, iv infliximab, sc golimumab, sc certolizumab, sc/iv abatacept, sc/iv tocilizumab or iv rituximab). Sociodemographic and clinical variables were obtained by structured interview and review of medical record.Degree of disease activity measures: DAS28 index (≤3.2:low activity; >3.2-≤5.1:moderate; >5.1:high) for RA and PA peripheral; BASDAI (<4:low activity ≥4:high activity) for AS and PA with predominant axial involvement. HRQoL was mesured by a self-administered questionnaire:EQ5D-5L2. It evaluates 5 dimensions:mobility (M), self-care, usual activities (UA)pain/discomfort (PD) and anxiety/depression. Each dimension has 5 levels of severity. A HRQoL score is obtained (EQ-index) from 0 (death) to 1 (full health). It also has a visual scale (EQ-VAS) of global health from 0 (the worst health) to 100 (the best health). Descriptive and multiple linear regression analysis (LRA) were performed to determine which variables contributed on HRQoL. Results A total of 382 patients were eligible for the study.314 patients agreed to answer the questionnaire (women:55.7%, average age (±SD): 55.2±13.9 years, average disease duration (±SD):13.05±8.1 years). Pathologies distribution: 44.3% RA, PA 26.1%, 21.3% AS, 8.3% O. BT: 51.9% ADA, 28.7% ETA and 19.4% others. 65.9% of patients had a first line of TB. 50% of patients had concomitant drug (corticosteroid/methotrexate/leflunomide). 71.7% of patients had low activity, with standard drug regimen (61.8%) and optimized regimen (37.6%). The EQ-index perceived was:0.73±0.22 and a global health EQ-VAS: 64.2±21.0 points. The worst rated questionnaire dimensions (severities 3–4-5) were P (33.7%), UA (29.9%) and M (26.7%). LRA showed significance differences (p<0.001) for disease activity, disease duration and education. 0.4 and 9.05 EQ-VAS points were reduced for each year of evolution and each DAS28 point increase, respectively. Differences were not significant for age, sex, pathology, drug or line number. Conclusions Generally, patients evaluated have a good control of disease activity and an acceptable HRQoL perceived. Chronic P and loss of autonomy to perform UA are the worst rated dimensions Gerhold K, Richter A, Schneider M, Bergerhausen HJ, Demary W, Liebhaber A, et al. Heailth-related quality of life in patients with long-standing rheumatoid arthritis in the era of biologics: data from the German...
Article 0 Reads 2 Citations Hydrological regime and modeling of three ponds of the Mediterranean area (south of Córdoba, Spain) Miguel Rodríguez-Rodríguez, Ana Fernández, Francisco Moral Published: 25 May 2016
Hydrobiologia, doi: 10.1007/s10750-016-2820-9
DOI See at publisher website
ABS Show/hide abstract
In this investigation, hydrological time series of three ponds located in the province of Córdoba (southern Spain) at a daily scale has been analyzed. For the first time, a detailed evolution of the water level of Jarales, Conde, and Amarga ponds has been acquired by means of the installation of level loggers in the deepest point of each of the ponds. We have modeled the water level evolution using a simple one-dimensional model. Calibration of the model was very satisfactory in two of the ponds. The model was then setup and simulated for two future Scenarios: A (IPCC climate change scenario) and B (climate change + groundwater withdrawal within the basin). Two ponds were classified as discharge ponds, which are the hydrological regime of the majority of southern Spain’s continental ponds. One was classified as a recharge pond. With regard to the results obtained in the simulations for Scenarios A and B, our results showed that IPCC scenario will reduce hydroperiod significantly in the three ponds, with a reduction of approximately 500 cm in the water level. With respect to groundwater withdrawal within the basins, results show a very high impact in the hydroperiod in Amarga and Conde ponds.
Article 0 Reads 1 Citation Applying piezometric evolution indicators to facilitate stakeholder’s participation in the management of groundwater-dep... Miguel Rodríguez-Rodríguez, Sergio Martos, Antonio Pedrera, ... Published: 24 February 2016
Hydrobiologia, doi: 10.1007/s10750-016-2670-5
DOI See at publisher website